HNGEMEDIUM SIGNALFINANCIAL10-Q

HNGE shows solid revenue growth but concerning balance sheet deterioration with accounts receivable substantially higher and stockholders' equity declining meaningfully.

The substantial increase in accounts receivable relative to revenue growth suggests potential collection challenges or extended payment terms that could impact cash flow quality. The significant decline in stockholders' equity combined with rising liabilities indicates deteriorating financial position that warrants monitoring.

Comparing 2025-11-07 vs 2025-08-11View on EDGAR →
FINANCIAL ANALYSIS

HNGE delivered solid operational performance with revenue growing 18% and gross profit expanding 22%, indicating improving margins. However, the balance sheet presents mixed signals as accounts receivable grew substantially faster than revenue while stockholders' equity declined meaningfully by $67 million. The combination of rising liabilities, reduced cash position, and disproportionate receivables growth suggests potential working capital management challenges despite strong top-line momentum.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
+74%
$66.1M$114.9M

Receivables surged 74% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Capital Expenditure
Cash Flow
+62.7%
$51K$83K

Capital expenditure jumped 62.7% — major investment cycle underway; assess returns on deployment.

Stockholders Equity
Balance Sheet
-37.5%
$178.7M$111.7M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Gross Profit
P&L
+22.2%
$126.2M$154.2M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Revenue
P&L
+18.2%
$154.2M$182.3M

Revenue growing 18.2% — solid top-line momentum, watch margins for quality of growth.

Current Liabilities
Balance Sheet
+14.4%
$362.4M$414.5M

Current liabilities rose 14.4% — increased short-term obligations, watch current ratio.

Total Liabilities
Balance Sheet
+13.9%
$366.2M$417.2M

Liabilities increased 13.9% — monitor debt-to-equity ratio and interest coverage.

Cash & Equivalents
Balance Sheet
-10.3%
$208.0M$186.7M

Cash decreased 10.3% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2025-11-07
PRIOR — 2025-08-11
ADDED
Electronic Health Records ( EHR ) Collection of patient health records electronically stored in a digital format.
Medicare Advantage Health plan for people aged 65 and older and others who are participating in Medicare that is managed by private insurance companies that contract with the U.S.
The unaudited condensed consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair statement of the condensed consolidated financial statements.
As of September 30, 2025 and December 31, 2024, total assets of the VIE, all of which are current, were $ 3.3 million and $ 4.0 million, respectively, and total liabilities, all of which are current, were $ 9.8 million and $ 6.3 million, respectively, after the elimination of intercompany transaction balances.
Additionally, no client represented greater than 10% of the Company s revenue for the three and nine months ended September 30, 2025 and 2024.
For the purpose of assessing the concentration of credit risk for significant clients, the Company defines a client as a business or organization that purchases access to the Company s platform directly from the Company or indirectly through one of the Company s partners.
Accounts receivable, net as of September 30, 2025 and December 31, 2024 was composed of the following (in thousands): September 30, December 31, 2025 2024 Billed accounts receivable $ 59,983 $ 37,658 Unbilled accounts receivable 34,033 11,307 Allowance for credit losses ( 7,251 ) ( 6,470 ) Total accounts receivable, net $ 86,765 $ 42,495 Allowances for credit losses are provided for those outstanding balances considered to be uncollectible based on the age of each outstanding invoice, historical collection history and the client s expected ability to pay.
Allowance for credit losses during the three and nine months ended September 30, 2025 and 2024 was composed of the following (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Balance, beginning of period $ 7,649 $ 5,619 $ 6,470 $ 3,439 Provision for credit losses 560 1,452 3,340 3,939 Write-off for credit losses, net ( 958 ) ( 425 ) ( 2,559 ) ( 732 ) Balance, end of period $ 7,251 $ 6,646 $ 7,251 $ 6,646 8 Hinge Health Inc.
As of September 30, 2025 and December 31, 2024, the deferred revenue balance was composed entirely of noncancellable performance obligations that will be satisfied within 12 months.
The Company recognized revenue of $ 130.7 million and $ 84.6 million for the three months ended September 30, 2025 and 2024, respectively, which was included in deferred revenue balances at the beginning of the respective periods.
REMOVED
Electronic Health Records ("EHR") Collection of patient health records electronically stored in a digital format.
Medicare Advantage Health plan for people aged 65 and older that is managed by private insurance companies that contract with the federal government.
Basis of Presentation The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with GAAP and regulations of the SEC for interim financial information.
As of June 30, 2025 and December 31, 2024 , total assets of the VIE, all of which are current, were $ 5.4 million and $ 4.0 million, respectively, and total liabilities, all of which are current, were $ 7.9 million and $ 6.3 million, respectively, after the elimination of intercompany transaction balances.
Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, marketable securities and trade accounts receivable.
Additionally, no client represented greater than 10% of the Company s revenue for the three and six months ended June 30, 2025 and 2024.
Accounts receivable, net as of June 30, 2025 and December 31, 2024 was composed of the following (in thousands): June 30, December 31, 2025 2024 Billed accounts receivable $ 69,830 $ 37,658 Unbilled accounts receivable 37,118 11,307 Allowance for credit losses ( 7,649 ) ( 6,470 ) Total accounts receivable, net $ 99,299 $ 42,495 Allowances for credit losses are provided for those outstanding balances considered to be uncollectible based on the age of each outstanding invoice, historical collection history and the client s expected ability to pay.
As of June 30, 2025 and December 31, 2024 , the deferred revenue balance was composed entirely of noncancellable performance obligations that will be satisfied within 12 months.
The Company determines revenue recognition through the following five steps: Identification of the contract, or contracts, with a client; Identification of the performance obligations in the contract; Determination of the transaction price; Allocation of the transaction price to the performance obligations in the contract; and Recognition of revenue when, or as, the Company satisfies a performance obligation.
The Company s contracts are billed after a member s first completed billing activity or throughout the service period upon the achievement of cohort milestones or based upon member engagement activity.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →